A constitutively internalizing and recycling mutant of the mu-opioid receptor

V Segredo1, N T Burford, J Lameh

  • 1Department of Biopharmaceutical Sciences and Pharmaceutical Chemistry, University of California, San Francisco 94143-0446, U.S.A.

Insights

A specific domain in the mu-opioid receptor normally suppresses internalization. Removing this domain causes spontaneous internalization without agonist or G protein activation, revealing distinct receptor trafficking mechanisms.

Area of Science:

  • Cell Biology
  • Molecular Pharmacology
  • Biochemistry

Background:

  • G protein-coupled receptors (GPCRs) internalization and recycling are typically agonist-dependent.
  • The mu-opioid receptor (MOR) is a key GPCR involved in pain signaling.
  • Constitutive recycling is observed in other receptor types, like the transferrin receptor.

Purpose of the Study:

  • To identify structural domains regulating mu-opioid receptor internalization.
  • To investigate the role of the C-terminal Ser/Thr-rich domain in MOR trafficking.
  • To determine if internalization can occur independently of agonist stimulation and G protein coupling.

Main Methods:

  • Construction and characterization of MOR C-terminal truncation mutants (Trunc354, Trunc363).
  • Ligand binding assays and G protein coupling measurements.
  • Immunocytochemistry and live-cell imaging to track receptor localization and internalization pathways (clathrin, caveolin).
  • Functional assays using hyperosmolar sucrose and acid treatment to block internalization.

Main Results:

  • Truncation mutant Trunc354 exhibited spontaneous, agonist-independent internalization into clathrin-coated vesicles.
  • This internalization occurred without elevated basal G protein coupling, suggesting uncoupled trafficking.
  • The C-terminal Ser/Thr-rich domain appears to suppress constitutive internalization.
  • Wild-type MOR and Trunc363 showed agonist-dependent internalization into clathrin-coated vesicles.

Conclusions:

  • The C-terminus of the mu-opioid receptor, particularly the Ser/Thr-rich domain, negatively regulates receptor internalization.
  • Constitutive internalization can be uncoupled from G protein activation, indicating distinct regulatory pathways.
  • This study demonstrates the construction of a GPCR mutant with spontaneous internalization, offering insights into receptor trafficking regulation.

Related Concept Videos

Receptor-mediated Endocytosis01:38

Receptor-mediated Endocytosis

Overview
Receptor-mediated Endocytosis01:20

Receptor-mediated Endocytosis

Receptor-mediated endocytosis is when bulk amounts of specific molecules are imported into a cell after binding to cell surface receptors. The molecules bound to these receptors are taken into the cell through inward folding of the cell surface membrane, which is eventually pinched off into a vesicle within the cell. Structural proteins, such as clathrin, coat the budding vesicle.
Clathrin-Mediated Endocytosis of LDL
One well-characterized example of receptor-mediated endocytosis is the...
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR activation may...
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
The Two-State Receptor Model01:29

The Two-State Receptor Model

The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...